What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001430681
Total reported value
$329.7K
$329.7K
93 檔
34457.6%
In Q4 2025, Hayek Kallen Investment Management's U.S. equity holdings reached a combined market value of $329.7K, distributed across 93 disclosed stock positions.
Hayek Kallen Investment Management executed strategic sector rebalancing during Q4 2025, establishing 92 new positions while fully exiting 93 holdings and trimming 0 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Stock-Other | 11.55% | — | — | ||
| 2 | ✓ | Stock-Other | 8.91% | — | — | ||
| 3 | ✓ | Stock-Other | 5.72% | — | — | ||
| 4 | ✓ | Stock-Other | 5.37% | — | — | ||
| 5 | ✓ | Stock-Other | 4.31% | — | — | ||
| 6 | ✓ | Stock-Other | 3.93% | — | — | ||
| 7 | ✓ | Stock-Other | 3.20% | — | — | ||
| 8 | ✓ | Stock-Other | 2.98% | — | — | ||
| 9 | ✓ | Stock-Other | 2.56% | — | — | ||
| 10 | ✓ | Stock-Other | 2.39% | — | — | ||
| 11 | ✓ | Abbott Laboratories | Stock-Other | 2.39% | — | — | |
| 12 | ✓ | Stock-Other | 2.37% | — | — | ||
| 13 | ✓ | Stock-Other | 2.31% | — | — | ||
| 14 | ✓ | Stock-Other | 2.27% | — | — | ||
| 15 | ✓ | Stock-Other | 1.81% | — | — | ||
| 16 | ✓ | Stock-Other | 1.74% | — | — | ||
| 17 | ✓ | Stock-Other | 1.69% | — | — | ||
| 18 | ✓ | Stock-Other | 1.69% | — | — | ||
| 19 | ✓ | Stock-Other | 1.67% | — | — | ||
| 20 | ✓ | Stock-Other | 1.59% | — | — | ||
| 21 | ✓ | Stock-Other | 1.51% | — | — | ||
| 22 | ✓ | Stock-Other | 1.42% | — | — | ||
| 23 | ✓ | Stock-Other | 1.27% | — | — | ||
| 24 | ✓ | Stock-Other | 1.23% | — | — | ||
| 25 | ✓ | Stock-Other | 1.18% | — | — | ||
| 26 | ✓ | Stock-Other | 1.16% | — | — | ||
| 27 | ✓ | Stock-Other | 1.07% | — | — | ||
| 28 | ✓ | Stock-Other | 0.95% | — | — | ||
| 29 | ✓ | Stock-Other | 0.86% | — | — | ||
| 30 | ✓ | Stock-Other | 0.79% | — | — | ||
| 31 | ✓ | Stock-Other | 0.79% | — | — | ||
| 32 | ✓ | Stock-Other | 0.78% | — | — | ||
| 33 | ✓ | Stock-Other | 0.77% | — | — | ||
| 34 | ✓ | Stock-Other | 0.76% | — | — | ||
| 35 | ✓ | Stock-Other | 0.74% | — | — | ||
| 36 | ✓ | Stock-Other | 0.71% | — | — | ||
| 37 | ✓ | Stock-Other | 0.71% | — | — | ||
| 38 | ✓ | Stock-Other | 0.69% | — | — | ||
| 39 | ✓ | Stock-Other | 0.68% | — | — | ||
| 40 | ✓ | Stock-Other | 0.64% | — | — | ||
| 41 | ✓ | Stock-Other | 0.57% | — | — | ||
| 42 | ✓ | Stock-Other | 0.52% | — | — | ||
| 43 | ✓ | Stock-Other | 0.52% | — | — | ||
| 44 | ✓ | Stock-Other | 0.50% | — | — | ||
| 45 | ✓ | Stock-Other | 0.41% | — | — | ||
| 46 | ✓ | Stock-Other | 0.39% | — | — | ||
| 47 | ✓ | Stock-Other | 0.39% | — | — | ||
| 48 | ✓ | Stock-Other | 0.39% | — | — | ||
| 49 | ✓ | Stock-Other | 0.33% | — | — | ||
| 50 | ✓ | Stock-Other | 0.32% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABT | Abbott Laboratories | 0% | — | Unchanged |
| 2 | ✓ | — | NEW | New buy | |
| 3 | AAPL | Apple Inc | — | EXIT | Sold out |
| 4 | MSFT | Microsoft CORP | — | EXIT | Sold out |
| 5 | ✓ | — | NEW | New buy | |
| 6 | BRK-B | Berkshire Hathaway Inc-cl B | — | EXIT | Sold out |
| 7 | ✓ | — | NEW | New buy | |
| 8 | ✓ | — | NEW | New buy | |
| 9 | ✓ | — | NEW | New buy | |
| 10 | GOOGL | Alphabet Inc-cl A | — | EXIT | Sold out |
| 11 | NVDA | Nvidia CORP | — | EXIT | Sold out |
| 12 | WMT | Walmart Inc | — | EXIT | Sold out |
| 13 | ✓ | — | NEW | New buy | |
| 14 | ORCL | Oracle CORP | — | EXIT | Sold out |
| 15 | WM | Waste Management Inc | — | EXIT | Sold out |
| 16 | ✓ | — | NEW | New buy | |
| 17 | ✓ | — | NEW | New buy | |
| 18 | JPM | Jpmorgan Chase & Co | — | EXIT | Sold out |
| 19 | ✓ | — | NEW | New buy | |
| 20 | IBM | Intl Business Machines CORP | — | EXIT | Sold out |
| 21 | ABBV | Abbvie Inc | — | EXIT | Sold out |
| 22 | ✓ | — | NEW | New buy | |
| 23 | ✓ | Abbott Laboratories | — | NEW | New buy |
| 24 | ✓ | — | NEW | New buy | |
| 25 | V | Visa Inc-class A Shares | — | EXIT | Sold out |
| 26 | ✓ | — | NEW | New buy | |
| 27 | ✓ | — | NEW | New buy | |
| 28 | JNJ | Johnson & Johnson | — | EXIT | Sold out |
| 29 | CAT | Caterpillar Inc | — | EXIT | Sold out |
| 30 | ✓ | — | NEW | New buy | |
| 31 | VZ | Verizon Communications Inc | — | EXIT | Sold out |
| 32 | ✓ | — | NEW | New buy | |
| 33 | ✓ | — | NEW | New buy | |
| 34 | ✓ | — | NEW | New buy | |
| 35 | ✓ | — | NEW | New buy | |
| 36 | SGOV | Ishares 0-3 Month Treasury B | — | EXIT | Sold out |
| 37 | AMZN | Amazon.com Inc | — | EXIT | Sold out |
| 38 | KO | Coca-cola Co/the | — | EXIT | Sold out |
| 39 | ✓ | — | NEW | New buy | |
| 40 | NVS | Novartis Ag-sponsored Adr | — | EXIT | Sold out |
| 41 | PM | Philip Morris International | — | EXIT | Sold out |
| 42 | ✓ | — | NEW | New buy | |
| 43 | UNP | Union Pacific CORP | — | EXIT | Sold out |
| 44 | TMO | Thermo Fisher Scientific Inc | — | EXIT | Sold out |
| 45 | ✓ | — | NEW | New buy | |
| 46 | JPST | Jpmorgan Ultra-short Income | — | EXIT | Sold out |
| 47 | ✓ | — | NEW | New buy | |
| 48 | ✓ | — | NEW | New buy | |
| 49 | BP | Bp Plc-spons Adr | — | EXIT | Sold out |
| 50 | ✓ | — | NEW | New buy |
According to official SEC Form 13F filings, Hayek Kallen Investment Management reported a total U.S. public equity portfolio value of $329.7K across 93 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including , , ) accounted for 34457.6% of total reported equity market value during Q4 2025.
Top New Position Initiated
市值: $36.6M
Top Position Liquidated / Trimmed
AAPL
前期市值: $34.8M
During Q4 2025, Hayek Kallen Investment Management's top holdings by market value included (11.6%)、 (8.9%)、 (5.7%). The largest single position, , represented 11.6% of total portfolio value.
In Q4 2025, Hayek Kallen Investment Management made 185 total portfolio adjustments, initiating 92 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 93 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.